Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Bismuth subgallate and borneol together improve skin wound healing better than when used separately or compared to other treatments.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Systemic agents like cyclosporine, methotrexate, and acitretin help manage psoriasis but have significant side effects.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

HS needs personalized treatment plans and more research.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

GI197111X is best dissolved in Capmul MCM for trials.

New cytokine-targeted therapies show promise for treating alopecia areata.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

A new psoriasis lotion called "Psorisbye" improved symptoms in a patient within one week.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.